NIKKEI 225
39,582.07 -1.01 (-0.00%) HANG SENG
17,718.61 +2.11 (+0.01%) CRUDE OIL
81.92 +0.38 (+0.47%) GOLD FUTURES
2,336.00 -3.60 (-0.15%) DOW
39,118.86 -45.24 (-0.12%) Bitcoin GBP
50,037.20 +2,030.03 (+4.23%)
SMMT Oct 2024 14.000 call
| Previous close | 0.8400 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 1.3500 |
| Strike | 14.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.8400 - 0.8400 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Business WireSummit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
MIAMI, June 27, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Jeff Huber has been appointed to its Board of Directors, effective immediately.
ZacksSummit (SMMT) Stock Surges 57% in the Past Month: Here's Why
Summit Therapeutics (SMMT) surges after data from a late-stage study shows that its experimental antibody beat Merck's Keytruda in a head-to-head setting in treating certain patients with lung cancer.
Business WireSummit Raises $200 Million; Also Expands License Territories for Ivonescimab
MIAMI, June 03, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the Company received and accepted an unsolicited offer from an institutional investor to purchase 22,222,222 shares of the Company’s common stock at $9.00 per share, a premium to the closing price on Friday, May, 31, 2024, for aggregate gross proceeds to the Company of approximately $200.0 million.
